ARCHIVES

NCI Proposal Would Give Drug Sponsors Commercial Rights To Biomarker Inventions

This article is from The Cancer Letter archive.

Vol. 35 No. 38 | October 16, 2009

Download PDF Visit The Full Archive

Related Articles

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

NCI Plans $175 Million In Program Cuts To Cover Deficit, Fund New Initiatives

November 17, 2006

NIH To Give 3 Percent Increase to Grants

March 20, 2009

DCT Board Gives Concept Approval to Recompetition Of In Vitro Assay For New Drug Screening Program

February 24, 1984

Obama Reiterates Support For Doubling Budgets For Cancer Research, Other Science Agencies

May 1, 2009

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

March 30, 2001